BMJ:美国阿片类药物处方情况研究——2003-17

2020-02-02 MedSci MedSci原创

研究发现,大多数医疗机构的日阿片处方剂量低于50MME的阈值,但大处方相对集中,长期应用延续的现象值得关注

近日研究人员就美国50个州及华盛顿特区的阿片药物使用情况进行了考察。

从2003年到2017年,全美平均每年有669495家医疗机构为390万名患者开出890万份阿片类药物处方。研究的主要终点为类阿片药物的标准化吗啡当量(MMEs)以及阿片处方的数量。

2017年,最高1%的医疗机构开具的阿片处方剂量占总剂量的49%,占总处方量的27%。按绝对值计算,上述最高1%机构处方剂量为748000MME--是平均剂量的1000倍。上述1%机构中,约50%的机构在相邻年份仍可进入最高1%。约40%日均剂量超过50MME的处方以及超过80%的7日以上处方由上述1%机构出具,而其他99%医疗机构中,86%的日均处方剂量低于50MME,时间少于7天。开具大剂量阿片处方的机构和接受大剂量阿片药物的患者长期存在,其中一半以上出现在相邻年份。

研究发现,大多数医疗机构的日阿片处方剂量低于50MME的阈值,但大处方相对集中,长期应用延续的现象值得关注。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848946, encodeId=13f71848946f3, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jul 13 19:43:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253103, encodeId=a19a1253103b3, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309149, encodeId=f6ee1309149c7, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
    2020-07-13 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848946, encodeId=13f71848946f3, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jul 13 19:43:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253103, encodeId=a19a1253103b3, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309149, encodeId=f6ee1309149c7, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1848946, encodeId=13f71848946f3, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jul 13 19:43:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253103, encodeId=a19a1253103b3, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309149, encodeId=f6ee1309149c7, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Tue Feb 04 01:43:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
    2020-02-04 lhlxtx

相关资讯

JAMA Surg:常见外科手术后阿片药物止痛治疗时长研究

研究认为,目前外科手术后的阿片处方疗程可以满足大部分患者的止痛需要,但对于骨外科以及神经外科的患者需要建立更为个性化的疼痛治疗方案

JAMA Surg:美国外科手术阿片药物使用调查

新的持续性阿片类药物使用可认为是一种常见的、先前被低估的外科手术神经并发症。

JAMA Pediatr:母婴同室成为新生儿戒断综合征首先治疗模式

研究认为,因宫内阿片类药物暴露导致新生儿戒断综合征患儿,接受母婴同室治疗可减少药物使用和住院时间,应成为NAS治疗的首选模式